In the blocked group, as shown in Figure 9C, the unlabeled ADH-1 significantly reduced 99mTc-HYNIC-ADH-1 PC9GR tumor uptake (T/N = 3.69 ± 0.50, p < 0.01), confirming the specificity of the labeled probe. Here, ADH1A is linked to neoplasm.